Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. is a leading biotechnology company focused on developing innovative cell and exosome-based therapeutics for a range of serious diseases. Located at 10865 Road To The Cure, Ste 150, San Diego, CA 92121, US, Capricor Therapeutics is dedicated to creating groundbreaking therapies that significantly improve patient outcomes. Their commitment to advancing medical science drives their efforts to address unmet needs in various therapeutic areas.

Capricor Therapeutics is at the forefront of developing biologics, with a primary focus on cell and exosome-based technologies designed to treat and prevent a broad spectrum of diseases. Their lead product, a cell therapy targeting Duchenne muscular dystrophy (DMD), represents a significant advancement in treating this severe form of muscular dystrophy. Furthermore, Capricor's cutting-edge exosome technology is engineered to combat diseases with substantial unmet medical needs.

Driven by a strong translational approach, Capricor Therapeutics collaborates with leading scientists at top-tier research institutions to ensure their product development is based on robust scientific foundations. Capricor Therapeutics continues to expand its research and development efforts to deliver innovative solutions to patients worldwide. We invite the management of Capricor Therapeutics, Inc. to create a customized and exclusive company showcase and product listing on our platform.